| Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes G Banumathy, V Singh, SR Pavithra, U Tatu Journal of Biological Chemistry 278 (20), 18336-18345, 2003 | 303 | 2003 |
| Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of … R Pallavi, N Roy, RK Nageshan, P Talukdar, SR Pavithra, R Reddy, ... Journal of Biological Chemistry 285 (49), 37964-37975, 2010 | 210 | 2010 |
| Systems analysis of chaperone networks in the malarial parasite Plasmodium falciparum SR Pavithra, R Kumar, U Tatu PLoS computational biology 3 (9), e168, 2007 | 154 | 2007 |
| Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1 T Mazor, C Chesnelong, A Pankov, LE Jalbert, C Hong, J Hayes, ... Proceedings of the National Academy of Sciences 114 (40), 10743-10748, 2017 | 151 | 2017 |
| Recurrent fever promotes Plasmodium falciparum development in human erythrocytes SR Pavithra, G Banumathy, O Joy, V Singh, U Tatu Journal of Biological Chemistry 279 (45), 46692-46699, 2004 | 140 | 2004 |
| IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism JL Izquierdo-Garcia, P Viswanath, P Eriksson, L Cai, M Radoul, ... Cancer research 75 (15), 2999-3009, 2015 | 139 | 2015 |
| Rapid conversion of mutant IDH1 from driver to passenger in a model of human gliomagenesis TCA Johannessen, J Mukherjee, P Viswanath, S Ohba, SM Ronen, ... Molecular Cancer Research 14 (10), 976-983, 2016 | 114 | 2016 |
| Metabolic reprogramming in mutant IDH1 glioma cells JL Izquierdo-Garcia, P Viswanath, P Eriksson, MM Chaumeil, RO Pieper, ... PloS one 10 (2), e0118781, 2015 | 98 | 2015 |
| Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India KMR Umadevi, K Ranganathan, S Pavithra, R Hemalatha, TR Saraswathi, ... Journal of oral pathology & medicine 36 (3), 136-141, 2007 | 91 | 2007 |
| Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate S Hameed P, S Solapure, V Patil, PP Henrich, PA Magistrado, S Bharath, ... Nature Communications 6 (1), 6715, 2015 | 80 | 2015 |
| Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring MM Chaumeil, M Radoul, C Najac, P Eriksson, P Viswanath, MD Blough, ... NeuroImage: Clinical 12, 180-189, 2016 | 74 | 2016 |
| Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process S Ohba, J Mukherjee, TC Johannessen, A Mancini, TT Chow, M Wood, ... Cancer research 76 (22), 6680-6689, 2016 | 65 | 2016 |
| PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival G Batsios, P Viswanath, E Subramani, C Najac, AM Gillespie, RD Santos, ... Scientific reports 9 (1), 10521, 2019 | 61 | 2019 |
| 2-hydroxyglutarate-mediated autophagy of the endoplasmic reticulum leads to an unusual downregulation of phospholipid biosynthesis in mutant IDH1 gliomas P Viswanath, M Radoul, JL Izquierdo-Garcia, WQ Ong, HA Luchman, ... Cancer research 78 (9), 2290-2304, 2018 | 61 | 2018 |
| Repositioning: the fast track to new anti-malarial medicines? J Lotharius, FJ Gamo-Benito, I Angulo-Barturen, J Clark, M Connelly, ... Malaria journal 13, 1-15, 2014 | 59 | 2014 |
| Three-dimensional structure of heat shock protein 90 from Plasmodium falciparum: molecular modelling approach to rational drug design against malaria R Kumar, SR Pavithra, U Tatu Journal of biosciences 32, 531-536, 2007 | 55 | 2007 |
| Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner P Viswanath, M Radoul, JL Izquierdo-Garcia, HA Luchman, ... Cancer & metabolism 6, 1-13, 2018 | 51 | 2018 |
| Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas P Viswanath, G Batsios, V Ayyappan, C Taglang, AM Gillespie, ... Neuro-oncology 23 (9), 1509-1522, 2021 | 38 | 2021 |
| MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma AR Molloy, C Najac, P Viswanath, A Lakhani, E Subramani, G Batsios, ... Theranostics 10 (19), 8757, 2020 | 38 | 2020 |
| Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters. P Viswanath, C Najac, JL Izquierdo-Garcia, A Pankov, C Hong, ... Oncotarget, 2016 | 37 | 2016 |